Office | USPTO |
Document type: | Patent |
Inventor(s): | Wagner José Fávaro; Nelson Eduardo Durán Caballero |
Applicant: | Universidade Estadual de Campinas Unicamp |
Year: | 2021 |
Application Number: | US20210238046 |
IPC: | A61K 39/39 A61P 31/00 A61P 35/00 C01B 25/02 C01C 1/02 C01F 5/32 |
Disclosed is a method for treating cancer in a subject by administering to the subject a compound selected from NH.sub.4MgPO.sub.4×6H.sub.2O, (NH.sub.4)2MgH.sub.2(PO.sub.4).sub.2×4H.sub.2O, (NH.sub.4)2Mg.sub.3(HPO.sub.4).sub.4×8H.sub.2O and NH.sub.4MgPO.sub.4×H.sub.2O associated or not to hydrolytic enzymes, which are known to have immunomodulatory activities.
FAPESP's process: | 17/04383-2 - New therapeutic perspective for non-muscle invasive bladder Cancer: use of the biological response modifier - inorganic phosphate complex 1 (MRB-CFI-1) |
Grantee: | Melissa Sena da Silva |
Principal Investigator: | Wagner José Fávaro |
Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) |
Support Opportunities: | Scholarships in Brazil - Scientific Initiation |